Skip to main content
. 2012 Mar 28;3:23. doi: 10.3389/fpsyt.2012.00023

Table 1.

Baseline demographic and biological characteristics*.

Outcome Ondansetron (N = 19)
Placebo (N = 22)
LL (N = 7) LS/SS (N = 12) LL (N = 7) LS/SS (N = 15)
Age in years 54.143 (8.764) 52.083 (16.572) 49.571 (14.547) 54.600 (12.988)
Sex, no. (%)
  Male 3 (43) 9 (75) 4 (57) 13 (93)
  Female 4 (57) 3 (25) 3 (43) 1 (7)
Race/ethnicity, no. (%)
  White 7 (100) 12 (100) 7 (100) 13 (87)
  Hispanic 2 (13)
Self-reported drinks/drinking day 0.540 (0.183) 0.625 (0.438) 0.535 (0.558) 0.506 (0.864)
Mean baseline expression 1.550 (0.593) 1.454 (0.605) 1.410 (0.724) 1.660 (0.514)
Breath alcohol concentration, % 0.000 0.000 0.000 0.003 (0.010)
Age of alcoholism onset in years 43.600 (16.906) 38.000 (17.311) 30.714 (10.610) 36.583 (19.528)
Social class, no. (%)
  1–3 4 8 5 9
  4–6 2 4 2 4
  7–9 1 1
Body mass index, kg/m2 17.122 (3.594) 26.405 (12.858) 22.997 (12.700) 17.841 (4.685)

*Values are expressed as mean (SD) unless otherwise indicated. All values were collected at the screening visit.

† Reflects mean values during the 90-day period preceding the screening visit.

‡Defined by Hollingshead and Redlich (1958).